Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Walzer KC"'
Autor:
Krähling V; Institute of Virology, Philipps University Marburg, Hans-Meerwein-Str. 2, 35043 Marburg, Germany; German Center for Infection Research (DZIF), Partner Site Gießen-Marburg-Langen, Marburg, Germany., Erbar S; BioNTech SE, An der Goldgrube 12, 55131 Mainz, Germany., Kupke A; Institute of Virology, Philipps University Marburg, Hans-Meerwein-Str. 2, 35043 Marburg, Germany; German Center for Infection Research (DZIF), Partner Site Gießen-Marburg-Langen, Marburg, Germany., Nogueira SS; BioNTech SE, An der Goldgrube 12, 55131 Mainz, Germany., Walzer KC; BioNTech SE, An der Goldgrube 12, 55131 Mainz, Germany., Berger H; BioNTech SE, An der Goldgrube 12, 55131 Mainz, Germany., Dietzel E; Institute of Virology, Philipps University Marburg, Hans-Meerwein-Str. 2, 35043 Marburg, Germany; German Center for Infection Research (DZIF), Partner Site Gießen-Marburg-Langen, Marburg, Germany., Halwe S; Institute of Virology, Philipps University Marburg, Hans-Meerwein-Str. 2, 35043 Marburg, Germany; German Center for Infection Research (DZIF), Partner Site Gießen-Marburg-Langen, Marburg, Germany., Rohde C; Institute of Virology, Philipps University Marburg, Hans-Meerwein-Str. 2, 35043 Marburg, Germany; German Center for Infection Research (DZIF), Partner Site Gießen-Marburg-Langen, Marburg, Germany., Sauerhering L; Institute of Virology, Philipps University Marburg, Hans-Meerwein-Str. 2, 35043 Marburg, Germany; German Center for Infection Research (DZIF), Partner Site Gießen-Marburg-Langen, Marburg, Germany., Aragão-Santiago L; BioNTech SE, An der Goldgrube 12, 55131 Mainz, Germany., Moreno Herrero J; BioNTech SE, An der Goldgrube 12, 55131 Mainz, Germany., Witzel S; TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH, Freiligrathstraße 12, 55131 Mainz, Germany., Haas H; BioNTech SE, An der Goldgrube 12, 55131 Mainz, Germany., Becker S; Institute of Virology, Philipps University Marburg, Hans-Meerwein-Str. 2, 35043 Marburg, Germany; German Center for Infection Research (DZIF), Partner Site Gießen-Marburg-Langen, Marburg, Germany. Electronic address: becker@staff.uni-marburg.de., Sahin U; BioNTech SE, An der Goldgrube 12, 55131 Mainz, Germany.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2023 Feb 01; Vol. 31 (2), pp. 374-386. Date of Electronic Publication: 2022 Oct 27.
Autor:
Andretto V; Univ. Lyon, Université Claude Bernard Lyon 1, CNRS, LAGEPP UMR 5007, 43 Boulevard du 11 Novembre 1918, F-69622, Villeurbanne, France., Repellin M; Univ. Lyon, Université Claude Bernard Lyon 1, CNRS, LAGEPP UMR 5007, 43 Boulevard du 11 Novembre 1918, F-69622, Villeurbanne, France., Pujol M; Univ. Lyon, Université Claude Bernard Lyon 1, CNRS, LAGEPP UMR 5007, 43 Boulevard du 11 Novembre 1918, F-69622, Villeurbanne, France., Almouazen E; Univ. Lyon, Université Claude Bernard Lyon 1, CNRS, LAGEPP UMR 5007, 43 Boulevard du 11 Novembre 1918, F-69622, Villeurbanne, France., Sidi-Boumedine J; Univ. Lyon, Université Claude Bernard Lyon 1, CNRS, LAGEPP UMR 5007, 43 Boulevard du 11 Novembre 1918, F-69622, Villeurbanne, France., Granjon T; Institut de Chimie et Biochimie Moléculaires et Supramoléculaires, ICBMS UMR 5246, Université de Lyon, Université Lyon 1, CNRS, F-69622 Lyon, France., Zhang H; Ghent Research Group on Nanomedicine, Laboratory of General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, 9000 Ghent, Belgium., Remaut K; Ghent Research Group on Nanomedicine, Laboratory of General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, 9000 Ghent, Belgium., Jordheim LP; Univ. Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon 69008, France., Briançon S; Univ. Lyon, Université Claude Bernard Lyon 1, CNRS, LAGEPP UMR 5007, 43 Boulevard du 11 Novembre 1918, F-69622, Villeurbanne, France., Keil IS; TRON Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH, Mainz, Germany., Vascotto F; TRON Translational Oncology at the University Medical Center of the Johannes Gutenberg University gGmbH, Mainz, Germany., Walzer KC; BioNTech SE, An der Goldgrube 12, 55131 Mainz, Germany., Sahin U; BioNTech SE, An der Goldgrube 12, 55131 Mainz, Germany., Haas H; BioNTech SE, An der Goldgrube 12, 55131 Mainz, Germany., Kryza D; Univ. Lyon, Université Claude Bernard Lyon 1, CNRS, LAGEPP UMR 5007, 43 Boulevard du 11 Novembre 1918, F-69622, Villeurbanne, France; Hospices Civils de Lyon, 69437 Lyon, France., Lollo G; Univ. Lyon, Université Claude Bernard Lyon 1, CNRS, LAGEPP UMR 5007, 43 Boulevard du 11 Novembre 1918, F-69622, Villeurbanne, France. Electronic address: giovanna.lollo@univ-lyon1.fr.
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2023 Jan; Vol. 353, pp. 1037-1049. Date of Electronic Publication: 2022 Dec 22.
Autor:
Muik A; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany., Lui BG; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany., Bacher M; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany., Wallisch AK; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany., Toker A; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany., Couto CIC; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany., Güler A; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany., Mampilli V; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany., Schmitt GJ; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany., Mottl J; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany., Ziegenhals T; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany., Fesser S; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany., Reinholz J; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany., Wernig F; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany., Schraut KG; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany., Hefesha H; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany., Cai H; Pfizer, 401 N. Middletown Rd., Pearl River, NY 10960, USA., Yang Q; Pfizer, 401 N. Middletown Rd., Pearl River, NY 10960, USA., Walzer KC; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany., Grosser J; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany., Strauss S; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany., Finlayson A; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany., Krüger K; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany., Ozhelvaci O; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany., Grikscheit K; Institute for Medical Virology, University Hospital, Goethe University Frankfurt, 60596 Frankfurt am Main, Germany., Kohmer N; Institute for Medical Virology, University Hospital, Goethe University Frankfurt, 60596 Frankfurt am Main, Germany., Ciesek S; Institute for Medical Virology, University Hospital, Goethe University Frankfurt, 60596 Frankfurt am Main, Germany.; DZIF-German Centre for Infection Research, External Partner Site, 60596 Frankfurt am Main, Germany., Swanson KA; Pfizer, 401 N. Middletown Rd., Pearl River, NY 10960, USA., Vogel AB; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany., Türeci Ö; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.; HI-TRON (Helmholtz Institute for Translational Oncology) Mainz by DKFZ, Obere Zahlbacherstr. 63, 55131 Mainz, Germany., Sahin U; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.; TRON gGmbH-Translational Oncology at the University Medical Center of the Johannes Gutenberg University, Freiligrathstraße 12, 55131 Mainz, Germany.
Publikováno v:
Science immunology [Sci Immunol] 2022 Dec 23; Vol. 7 (78), pp. eade9888. Date of Electronic Publication: 2022 Dec 23.
Autor:
Vogel AB; BioNTech, Mainz, Germany., Kanevsky I; Pfizer, Pearl River, NY, USA., Che Y; Pfizer, Groton, CT, USA., Swanson KA; Pfizer, Pearl River, NY, USA., Muik A; BioNTech, Mainz, Germany., Vormehr M; BioNTech, Mainz, Germany., Kranz LM; BioNTech, Mainz, Germany., Walzer KC; BioNTech, Mainz, Germany., Hein S; BioNTech, Mainz, Germany., Güler A; BioNTech, Mainz, Germany., Loschko J; Pfizer, Pearl River, NY, USA., Maddur MS; Pfizer, Pearl River, NY, USA., Ota-Setlik A; Pfizer, Pearl River, NY, USA., Tompkins K; Pfizer, Pearl River, NY, USA., Cole J; Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA., Lui BG; BioNTech, Mainz, Germany., Ziegenhals T; BioNTech, Mainz, Germany., Plaschke A; BioNTech, Mainz, Germany., Eisel D; BioNTech, Mainz, Germany., Dany SC; BioNTech, Mainz, Germany., Fesser S; BioNTech, Mainz, Germany., Erbar S; BioNTech, Mainz, Germany., Bates F; BioNTech, Mainz, Germany., Schneider D; BioNTech, Mainz, Germany., Jesionek B; BioNTech, Mainz, Germany., Sänger B; BioNTech, Mainz, Germany., Wallisch AK; BioNTech, Mainz, Germany., Feuchter Y; BioNTech, Mainz, Germany., Junginger H; BioNTech, Mainz, Germany., Krumm SA; BioNTech, Mainz, Germany., Heinen AP; BioNTech, Mainz, Germany., Adams-Quack P; BioNTech, Mainz, Germany., Schlereth J; BioNTech, Mainz, Germany., Schille S; BioNTech, Mainz, Germany., Kröner C; BioNTech, Mainz, Germany., de la Caridad Güimil Garcia R; BioNTech, Mainz, Germany., Hiller T; BioNTech, Mainz, Germany., Fischer L; BioNTech, Mainz, Germany., Sellers RS; Pfizer, Pearl River, NY, USA., Choudhary S; Pfizer, Pearl River, NY, USA., Gonzalez O; Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA., Vascotto F; TRON-Translational Oncology at the University Medical Centre of the Johannes Gutenberg University, Mainz, Germany., Gutman MR; VCA SouthPaws Veterinary Specialists and Emergency Center, Fairfax, VA, USA., Fontenot JA; New Iberia Research Center, New Iberia, LA, USA., Hall-Ursone S; Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA., Brasky K; Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA., Griffor MC; Pfizer, Groton, CT, USA., Han S; Pfizer, Groton, CT, USA., Su AAH; BioNTech, Mainz, Germany., Lees JA; Pfizer, Groton, CT, USA., Nedoma NL; Pfizer, Groton, CT, USA., Mashalidis EH; Pfizer, Groton, CT, USA., Sahasrabudhe PV; Pfizer, Groton, CT, USA., Tan CY; Pfizer, Pearl River, NY, USA., Pavliakova D; Pfizer, Pearl River, NY, USA., Singh G; Pfizer, Pearl River, NY, USA., Fontes-Garfias C; University of Texas Medical Branch, Galveston, TX, USA., Pride M; Pfizer, Pearl River, NY, USA., Scully IL; Pfizer, Pearl River, NY, USA., Ciolino T; Pfizer, Pearl River, NY, USA., Obregon J; Pfizer, Pearl River, NY, USA., Gazi M; Texas Biomedical Research Institute, San Antonio, TX, USA., Carrion R Jr; Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA., Alfson KJ; Texas Biomedical Research Institute, San Antonio, TX, USA., Kalina WV; Pfizer, Pearl River, NY, USA., Kaushal D; Southwest National Primate Research Center, Texas Biomedical Research Institute, San Antonio, TX, USA., Shi PY; University of Texas Medical Branch, Galveston, TX, USA., Klamp T; BioNTech, Mainz, Germany., Rosenbaum C; BioNTech, Mainz, Germany., Kuhn AN; BioNTech, Mainz, Germany., Türeci Ö; BioNTech, Mainz, Germany., Dormitzer PR; Pfizer, Pearl River, NY, USA., Jansen KU; Pfizer, Pearl River, NY, USA., Sahin U; BioNTech, Mainz, Germany. Ugur.Sahin@biontech.de.; TRON-Translational Oncology at the University Medical Centre of the Johannes Gutenberg University, Mainz, Germany. Ugur.Sahin@biontech.de.
Publikováno v:
Nature [Nature] 2021 Apr; Vol. 592 (7853), pp. 283-289. Date of Electronic Publication: 2021 Feb 01.
Autor:
Vormehr M; BioNTech RNA Pharmaceuticals, Mainz, Germany.; Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University, Mainz, Germany., Lehar S; Genentech Inc., South San Francisco, CA, USA., Kranz LM; BioNTech RNA Pharmaceuticals, Mainz, Germany., Tahtinen S; Genentech Inc., South San Francisco, CA, USA., Oei Y; Genentech Inc., South San Francisco, CA, USA., Javinal V; BioNTech RNA Pharmaceuticals, Mainz, Germany.; Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University, Mainz, Germany.; Genentech Inc., South San Francisco, CA, USA.; BioNTech SE, Mainz, Germany.; TRON - Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Mainz, Germany., Delamarre L; Genentech Inc., South San Francisco, CA, USA., Walzer KC; BioNTech SE, Mainz, Germany., Diken M; BioNTech RNA Pharmaceuticals, Mainz, Germany.; TRON - Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Mainz, Germany., Kreiter S; BioNTech RNA Pharmaceuticals, Mainz, Germany.; TRON - Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Mainz, Germany., Mellman I; Genentech Inc., South San Francisco, CA, USA., Sahin U; Research Center for Immunotherapy (FZI), University Medical Center of the Johannes Gutenberg University, Mainz, Germany.; TRON - Translational Oncology at the University Medical Center of Johannes Gutenberg University gGmbH, Mainz, Germany.; BioNTech SE, Mainz, Germany., Schartner JM; Genentech Inc., South San Francisco, CA, USA., Türeci Ö; BioNTech SE, Mainz, Germany.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2020 May 13; Vol. 9 (1), pp. 1758004. Date of Electronic Publication: 2020 May 13.
Autor:
Beissert T; TRON (Translational Oncology at the University Medical Center), Johannes Gutenberg University Mainz, Mainz, Germany., Perkovic M; TRON (Translational Oncology at the University Medical Center), Johannes Gutenberg University Mainz, Mainz, Germany., Vogel A; BioNTech AG, Mainz, Germany., Erbar S; BioNTech AG, Mainz, Germany., Walzer KC; BioNTech AG, Mainz, Germany., Hempel T; TRON (Translational Oncology at the University Medical Center), Johannes Gutenberg University Mainz, Mainz, Germany., Brill S; TRON (Translational Oncology at the University Medical Center), Johannes Gutenberg University Mainz, Mainz, Germany., Haefner E; Department for Internal Medicine, Johannes Gutenberg University Mainz, Mainz, Germany., Becker R; TRON (Translational Oncology at the University Medical Center), Johannes Gutenberg University Mainz, Mainz, Germany., Türeci Ö; BioNTech AG, Mainz, Germany., Sahin U; TRON (Translational Oncology at the University Medical Center), Johannes Gutenberg University Mainz, Mainz, Germany; BioNTech AG, Mainz, Germany; Department for Internal Medicine, Johannes Gutenberg University Mainz, Mainz, Germany. Electronic address: ugur.sahin@tron-mainz.de.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2020 Jan 08; Vol. 28 (1), pp. 119-128. Date of Electronic Publication: 2019 Sep 12.
Autor:
Vascotto F; TRON - Translational Oncology, University Medical Center of Johannes Gutenberg University gGmbH, Mainz, Germany., Petschenka J; TRON - Translational Oncology, University Medical Center of Johannes Gutenberg University gGmbH, Mainz, Germany., Walzer KC; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany., Vormehr M; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany., Brkic M; TRON - Translational Oncology, University Medical Center of Johannes Gutenberg University gGmbH, Mainz, Germany., Strobl S; BioNTech Small Molecules GmbH, Martinsried, Germany., Rösemann R; BioNTech Small Molecules GmbH, Martinsried, Germany., Diken M; TRON - Translational Oncology, University Medical Center of Johannes Gutenberg University gGmbH, Mainz, Germany.; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany., Kreiter S; TRON - Translational Oncology, University Medical Center of Johannes Gutenberg University gGmbH, Mainz, Germany.; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany., Türeci Ö; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany., Sahin U; TRON - Translational Oncology, University Medical Center of Johannes Gutenberg University gGmbH, Mainz, Germany.; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany.; Research Center for Immunotherapy (FZI), University Medical Center at the Johannes Gutenberg University, Mainz, Germany.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2019 Apr 19; Vol. 8 (7), pp. 1601480. Date of Electronic Publication: 2019 Apr 19 (Print Publication: 2019).
Autor:
Pektor S; Department of Nuclear Medicine, University Medical Center Mainz of Johannes Gutenberg University Mainz, Mainz, Germany., Hilscher L; TRON - Translational Oncology at the University Medical Center of Johannes Gutenberg University Mainz gGmbH, Mainz, Germany., Walzer KC; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany., Miederer I; Department of Nuclear Medicine, University Medical Center Mainz of Johannes Gutenberg University Mainz, Mainz, Germany., Bausbacher N; Department of Nuclear Medicine, University Medical Center Mainz of Johannes Gutenberg University Mainz, Mainz, Germany., Loquai C; Department of Dermatology, University Medical Center Mainz of Johannes Gutenberg University Mainz, Mainz, Germany., Schreckenberger M; Department of Nuclear Medicine, University Medical Center Mainz of Johannes Gutenberg University Mainz, Mainz, Germany., Sahin U; TRON - Translational Oncology at the University Medical Center of Johannes Gutenberg University Mainz gGmbH, Mainz, Germany.; Biopharmaceutical New Technologies (BioNTech) Corporation, Mainz, Germany., Diken M; TRON - Translational Oncology at the University Medical Center of Johannes Gutenberg University Mainz gGmbH, Mainz, Germany., Miederer M; Department of Nuclear Medicine, University Medical Center Mainz of Johannes Gutenberg University Mainz, Mainz, Germany. Matthias.miederer@unimedizin-mainz.de.
Publikováno v:
EJNMMI research [EJNMMI Res] 2018 Aug 15; Vol. 8 (1), pp. 80. Date of Electronic Publication: 2018 Aug 15.
Autor:
Beissert T; 1 TRON-Translational Oncology , Mainz, Germany ., Koste L; 2 III Medical Clinic at the University Medical Center of the Johannes Gutenberg University Mainz , Mainz, Germany ., Perkovic M; 1 TRON-Translational Oncology , Mainz, Germany ., Walzer KC; 3 BioNTech AG , Mainz, Germany ., Erbar S; 4 BioNTech RNA Pharmaceuticals GmbH , Mainz, Germany ., Selmi A; 1 TRON-Translational Oncology , Mainz, Germany ., Diken M; 1 TRON-Translational Oncology , Mainz, Germany ., Kreiter S; 1 TRON-Translational Oncology , Mainz, Germany ., Türeci Ö; 5 CI3-Cluster for Individualized Immune Intervention , Mainz, Germany ., Sahin U; 1 TRON-Translational Oncology , Mainz, Germany .; 2 III Medical Clinic at the University Medical Center of the Johannes Gutenberg University Mainz , Mainz, Germany .; 3 BioNTech AG , Mainz, Germany .
Publikováno v:
Human gene therapy [Hum Gene Ther] 2017 Dec; Vol. 28 (12), pp. 1138-1146. Date of Electronic Publication: 2017 Sep 06.